Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide vs Compazine for Migraine in ED
NCT00274170Phase 2Unknown
- Sponsor
- Carl R. Darnall Army Medical Center
- Start
- Jan 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of octreotide in migraine, sponsored by Carl R. Darnall Army Medical Center. Status: unknown.
02
Drugs
octreotide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00274170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274170.